Cytosorbents (CTSO) Long-Term Deferred Tax (2018 - 2021)
Cytosorbents' (CTSO) quarterly Long-Term Deferred Tax came in at $27.2 million in Q4 2021, up 7.79% YoY from $25.2 million in Q4 2020, and up 7.79% on a QoQ basis from $25.2 million in Q4 2020.
Cytosorbents (CTSO) Long-Term Deferred Tax (2018 - 2021) Analysis & Trends
Cytosorbents (CTSO) has 4 years of Long-Term Deferred Tax data on file, last reported at $27.2 million in Q4 2021.
- Quarterly Long-Term Deferred Tax rose 7.79% year-over-year to $27.2 million in Q4 2021, while the trailing twelve-month figure through Dec 2021 was $27.2 million (up 7.79% YoY) and the FY2021 annual result came in at $27.2 million, up 7.79% from the prior year.
- Long-Term Deferred Tax advanced to $27.2 million in Q4 2021, from $25.2 million in the prior quarter.
- In the past five years, Long-Term Deferred Tax ranged from a high of $27.2 million in Q4 2021 to a low of $21856.0 in Q4 2018.
- A 4-year average of $18.9 million and a median of $24.2 million in 2019 frame the typical range for Long-Term Deferred Tax.
- Annual changes were most pronounced in 2019 — Long-Term Deferred Tax soared 106285.61% — and 2021, when it advanced 7.79%.
- Tracing CTSO's Long-Term Deferred Tax over 4 years: stood at $21856.0 in 2018, then soared by 106285.61% to $23.3 million in 2019, then increased by 8.49% to $25.2 million in 2020, then grew by 7.79% to $27.2 million in 2021.
- The last three Long-Term Deferred Tax figures came in at $27.2 million (Q4 2021), $25.2 million (Q4 2020), and $23.3 million (Q4 2019), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 198.70 Bn | 193.10 Bn | 7.27 Bn |
| 2 | Stryker | 125.85 Bn | 122.37 Bn | 4.50 Bn |
| 3 | Medtronic | 118.44 Bn | 109.22 Bn | 6.41 Bn |
| 4 | Boston Scientific | 72.64 Bn | 72.10 Bn | 3.85 Bn |
| 5 | Edwards Lifesciences | 51.94 Bn | 47.69 Bn | 1.35 Bn |
| 6 | Dexcom | 34.48 Bn | 32.53 Bn | 830.00 Mn |
| 7 | GE HealthCare Technologies | 33.60 Bn | 31.49 Bn | 2.18 Bn |
| 8 | Koninklijke Philips | 26.30 Bn | 22.98 Bn | 4.55 Bn |
| 9 | Steris | 23.00 Bn | 22.52 Bn | 684.20 Mn |
| 10 | Cytosorbents | 19.47 Mn | 15.06 Mn | 7.05 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2021 | 27.19 Mn |
| Dec 31, 2020 | 25.23 Mn |
| Dec 31, 2019 | 23.25 Mn |
| Dec 31, 2018 | 21,856.00 |